31 results
10-K
2023 FY
EX-4.14
SKYE
Skye Bioscience Inc
Annual report
21 Mar 24
8:41pm
8-K
EX-4.1
SKYE
Skye Bioscience Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:13pm
8-K
EX-4.1
SKYE
Skye Bioscience Inc
29 Jan 24
Skye Bioscience Announces $50.25 Million Private Placement Equity Financing
8:02am
8-K
EX-4.2
SKYE
Skye Bioscience Inc
21 Aug 23
Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
8:36am
8-K
EX-4.1
SKYE
Skye Bioscience Inc
21 Aug 23
Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
8:36am
8-K
EX-4.3
wa7cb s6ma
21 Aug 23
Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
8:36am
8-K
EX-4.3
pu2yn6lllacn93uljl
28 Sep 21
Skye Bioscience Announces $7.0 Million Registered Direct Offering
8:45am
8-K
EX-4.1
ww3h0
28 Sep 21
Skye Bioscience Announces $7.0 Million Registered Direct Offering
8:45am
8-K
EX-4.2
n3po3r f17l
28 Sep 21
Skye Bioscience Announces $7.0 Million Registered Direct Offering
8:45am
8-K
EX-4.1
dii03rsa
5 Aug 20
Emerald Bioscience Raises approximately $7.0 Million in Upsized Registered Offering
12:00am
8-K
EX-4.2
gtj3j9k 7v5
5 Aug 20
Emerald Bioscience Raises approximately $7.0 Million in Upsized Registered Offering
12:00am
8-K
EX-4.1
nu1vri
21 Nov 19
Emerald Bioscience Announces $2.0 Million Registered Direct Offering
5:21pm
S-8
EX-4.2
bwhzc40lnans457vm5vi
16 Oct 18
Registration of securities for employees
4:36pm